Alejandro Romero at Universidad Complutense de Madrid Facultad de Veterinaria - Research Interests, Publications & Academic Profile

Alejandro Romero

Profesor Titular de Universidad

Universidad Complutense de Madrid Facultad de Veterinaria

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Nigerian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

80%

Pharmacotherapy

40%

Melatonin

60%

Antioxidant Therapy

30%

Neuropharmacology

30%

Toxicology

20%

Coronavirus Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Discovery Patterns of Drugs Approved for Treating Bipolar Disorder by Applying Operational Criteria of Serendipity: A Historical Analysis

Article Link

Year:

2024

Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability

Article Link

Year:

2024

The Fungicide Ipconazole Can Activate Mediators of Cellular Damage in Rat Brain Regions

Article Link

Year:

2024

Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics

Article Link

Year:

2023

Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review

Article Link

Year:

2023

Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4

Article Link

Year:

2023

Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue

Article Link

Year:

2023

Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging

Article Link

Year:

2023

In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration

Article Link

Year:

2022

Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?

Article Link

Year:

2022

The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy

Article Link

Year:

2021

Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

Article Link

Year:

2021

In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral N-Propargyl-1,2-amino Alcohol Derivatives

Article Link

Year:

2021

Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux

Article Link

Year:

2020

Collaborators11

EMILIO GIL MARTÍN

Professor of Biochemistry and Molecular Biology

Universidade de Vigo

SPAIN

Juan Torrado

Profesor

Universidad Complutense de Madrid

SPAIN

Francisco López-Muñoz

Universidad Camilo José Cela

SPAIN

Victoria Jiménez Carretero

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

Russel Reiter

Professor

UNITED STATES

Luca Casettari

Full Professor

Università degli Studi di Urbino Carlo Bo Dipartimento di Scienze Biomolecolari

ITALY

Dolores Remedios Serrano

Assitant Professor - Profesor Ayudante Doctor

Universidad Complutense de Madrid

SPAIN

Cristobal de los Rios

Profesor Contratado Doctor (Lecturer)

Universidad Rey Juan Carlos - Campus de Fuenlabrada

SPAIN

Jose Antonio Guerra Guirao

Assistant Professor of toxicology and Pharmacology

Universidad Complutense de Madrid

SPAIN

Domenico De Berardis

Adjunct Professor of Pharmacology

University of L'Aquila

ITALY

Ana I Casas

Assistant Profesor (Double Affiliation with UKE)

University of Maastricht

NETHERLANDS

How do Nigerian students reach out?

Meet Kite AI